Triazolones as fatty acid synthase inhibitors
US9340529B2 · kind B2 · utility
0Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 4, 2013 |
| Grant date | May 17, 2016 |
| Priority date | — |
| Expiry date | Mar 20, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the use of triazolone derivatives for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of triazolones in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.